T1	Participants 368 412	Chinese patients with essential hypertension
T2	Participants 471 514	Informed consent were given by all patients
T3	Participants 556 613	105 patients with mild or moderate essential hypertension
T4	Participants 851 969	Only those patients who have finished 8 weeks of active treatment in both groups were included into the final analysis
T5	Participants 979 1074	One hundred one patients (51 in enalapril group and 50 in indapamide group) completed the study
